All fentanyl-related substances could soon be classified as Schedule I substances by the Attorney General and the Drug Enforcement Administration. The bipartisan but Republican-led Halt All Lethal Trafficking of Fentanyl Act, also called the “HALT” Fentanyl Act, cleared the House and Senate as of June 12 and will soon hit President Trump’s desk to be […]

This is an exclusive BHB+ story Tobacco cessation services often rank low on the list of offerings for substance use disorder providers. Still, there could be a business opportunity to expand offerings in this space. Tobacco use is still the leading cause of preventable death in the U.S., responsible for just under half a million […]

The House of Representatives has reauthorized the  SUPPORT for Patients and Communities Act, extending federal programs focused on combating the opioid epidemic.  The legislation, which was initially signed into law in 2018, focused on opioid prevention, treatment and recovery programs. Specifically, it expands treatment options for pregnant and postpartum women with a substance use disorder. […]

The safety-net and nonprofit segments of the addiction treatment industry have long faced immense challenges. But those challenges have produced some of the most compelling innovations in terms of clinical, operational and reimbursement models. One key element of this development is the necessity to understand a community’s needs, Beth Keeney, CEO and president of Jeffersonville, […]

In the rapidly evolving landscape of addiction treatment, legacy providers are increasingly under pressure to adapt without abandoning the principles that built their reputations. Few organizations embody this balancing act better than Hazelden Betty Ford Foundation, one of the nation’s largest nonprofit providers of substance use disorder (SUD) care, recovery resources, and related prevention and […]

There’s a strong case to be made that the payer and reimbursement landscape for substance use disorder (SUD) treatment providers is the most challenging in all of behavioral health care due to several deeply entrenched and overlapping issues. For starters, SUD treatment has, in the past, been viewed as less legitimate than other forms of […]

Opioid use disorder (OUD) costs the U.S. around $94.3 billion annually. To put that in perspective, that’s the same amount the President of the Philippines asked for to support its entire government budget in 2023. The price tag per person among the 6.1 million people who have an OUD lands somewhere around $700,000 per case. […]

Addiction treatment provider Eleanor Health has officially launched online therapy services in New Mexico, marking the ninth state the company has operations in. Services began April 28. Eleanor is currently focused on marketing its new offering throughout the state and awaiting members. The company chose to expand to the New Mexico market after evaluating geographical […]

As more adults over 65 develop chronic substance use problems, the landscape of available options, particularly for those who receive Medicare, is also rapidly changing. Deadly drug overdoses quadrupled for older adults between 2002 and 2021, but among Medicare beneficiaries with a substance use disorder (SUD), fewer than one in five receive medication-assisted-treatment (MAT).  Opioid […]

After years of surges in drug overdose deaths, the number of fatalities has declined in recent years. The CDC reported a 24% decline in overdose-related deaths in the 12 months ending in September 2024, compared to the previous year. Still, researchers warn that cutbacks in Medicaid coverage and programming could lead to an uptick in […]